Search

… from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. About …

… from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. About …

… NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), an innovative biopharmaceutical company engaged in the discovery … proceeds from borrowings, representing receipts from our Innovation credit grant. As of September 30, 2014, we held … after market authorization. About ProQR ProQR is an innovative biopharmaceutical company engaged in the discovery …

… programs towards the clinic in our effort to bring more innovative medicines for inherited retinal diseases to … abstract was presented at the Retinal Cell & Gene Therapy Innovation Summit, three abstracts were presented at the …

… from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 633545. …

… proceeds from borrowings, representing receipts from our innovation credit from the Dutch government for our cystic …

… at the Seventh Annual Retinal Cell and Gene Therapy Innovation Summit, April 29, 2022, and the Association for …

… around the end of 2020. In December, ProQR was awarded an innovation credit by the Dutch government for the clinical …